|
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
RECRUITINGSponsored by Hebei Medical University Fourth Hospital
Actively Recruiting
SponsorHebei Medical University Fourth Hospital
Started2020-11-19
Est. completion2026-11-19
Eligibility
Age55 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06375798
Summary
A Single-center, open, prospective study,for analyzing the local recurrence rate, the incidence of incision complications and the aesthetic effect of intraoperative radiotherapy in early breast cancer patients after breast-conserving surgery.
Eligibility
Age: 55 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: 1. Age ≥55 years old; 2. Cytology or histology confirmed invasive breast cancer or intraductal carcinoma in situ (DCIS) with a clinical stage of Tis-1N0M0; 3. Patients who are willing to preserve milk and intend to undergo breast-conserving surgery; 4. If invasive breast cancer is confirmed, the surgical margin negative ≥2mm should be met. If DCIS is confirmed, the surgical margin should be negative ≥3mm; 5. ER≥ 30% and PR≥ 1%, HER2 negative; 6. Voluntary participation in this study, signed informed consent, good compliance, cooperate with follow-up. Exclusion Criteria: 1. Simultaneous diagnosis of bilateral or multifocal breast cancer; 2. Previous ipsilateral breast cancer and/or prior chest wall radiation therapy; 3. There are active connective tissue diseases such as scleroderma and systemic lupus erythematosus in the chest; 4. The investigators did not consider the patient suitable for participation in any other conditions of the study.
Conditions3
Breast CancerCancerHER2-negative Breast Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorHebei Medical University Fourth Hospital
Started2020-11-19
Est. completion2026-11-19
Eligibility
Age55 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06375798